Whether improved glucose control with hybrid closed-loop therapy can preserve C-peptide secretion as compared with standard insulin therapy in persons with new-onset type 1 diabetes is unclear. A ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results